<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02970409</url>
  </required_header>
  <id_info>
    <org_study_id>FIBHGM-ECNC002-2014</org_study_id>
    <nct_id>NCT02970409</nct_id>
  </id_info>
  <brief_title>Heparin Versus Saline in Peripheral Venous Catheter</brief_title>
  <official_title>A Randomized Study to Test Peripheral Venous Catheter Lock Therapy With Either Heparin or Saline in Patients Admitted to the Internal Medicine Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Universitario Gregorio Marañon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundación para la Investigación Biomédica del Hospital Gregorio Maranon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital General Universitario Gregorio Marañon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A clinical, prospective. controlled and randomized study with patients with a peripheral
      venous catheter. Patients will be randomized to either receive heparin or saline. The
      investigators will monitored the clinical out come to further evaluate catheter colonization
      rate, phlebitis rate, days of hospital stay, antimicrobial costs, and adverse effects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The need of use of peripheral venous catheters and the importance of a proper management to
      avoid catheter colonization or phlebitis requires two possible preventive approaches: lock
      therapy with heparin or saline.

      Heparin demonstrated its efficacy in central venous catheters, but there are still
      controversies of whether it is useful in peripheral venous catheters.

      Objectives To compare the efficacy of heparin in peripheral venous catheters lock versus
      saline for the prevention of colonization and phlebitis in patients admitted to an Internal
      Medicine Department.

      Methods: A clinical, prospective. controlled and randomized study with patients with a
      peripheral venous catheter.

      Patients will be randomized to either receive heparin or saline. The investigators will
      monitored the clinical out come to further evaluate catheter colonization rate, phlebitis
      rate, days of hospital stay, antimicrobial costs, and adverse effects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>complications</measure>
    <time_frame>Daily from catheter insertion until catheter withdraw(estimated 10 days)</time_frame>
    <description>prevention of colonization(superficial and tip culture) and phlebitis(visual inflammation of entrance of catheter insertion) .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>catheter related infection rate</measure>
    <time_frame>Through study completion( estimated 2 year after Last patient in)</time_frame>
    <description>episodes of catheter related infection against number of days of exposure to catheter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse events(number of catheter obstructions and coagulation alterations)</measure>
    <time_frame>Through study completion (2 year afterLast patient in)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">950</enrollment>
  <condition>Catheter-Related Infections</condition>
  <arm_group>
    <arm_group_label>heparin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Catheter Lock Therapy with Heparin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Catheter Lock Therapy with saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>catheter lock using saline</description>
    <arm_group_label>saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Heparin</intervention_name>
    <description>catheter lock using Heparin</description>
    <arm_group_label>heparin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with inserted PV Catheter within 24h from admission in internal medicine

        Exclusion Criteria:

          -  hypersensibility to heparin

          -  active hemorrhage

          -  coagulation alterations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Emilio Bouza, PhD</last_name>
    <phone>+34915868452</phone>
    <email>emilio.bouza@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Guembe, PhD</last_name>
    <phone>+34915868453</phone>
    <email>mariaguembe@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Internal Medicine Department HGU Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emilio Bouza, PhD</last_name>
      <phone>+34915868452</phone>
      <email>emilio.bouza@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2015</study_first_submitted>
  <study_first_submitted_qc>November 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2016</study_first_posted>
  <last_update_submitted>November 21, 2016</last_update_submitted>
  <last_update_submitted_qc>November 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Catheter-Related Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

